1-7 of 7
Holly McConville, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase IIa Trial of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+ Lymphomas

Stephen J. Schuster, MD, Jakub Svoboda, MD, Sunita Dwivedy Nasta, MD, David L. Porter, MD, Elise A. Chong, MD, Yolanda Mahnke, PhD, Simon F. Lacey, PhD BSc, J. Joseph Melenhorst, PhD, Anne Chew, PhD, Gaurav Shah, MD, Jens Hasskarl, MD, Manuel Litchman, MD, Mariusz A. Wasik, MD, Daniel J. Landsburg, MD, Anthony R. Mato, MD MSCE, Alfred L. Garfall, MD, Noelle V. Frey, MDMS, Katherine T. Marcucci, PhD, Joanne Shea, RN, Holly McConville, RN, BSN, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 3087.
https://doi.org/10.1182/blood.V124.21.3087.3087
Published: 2014
Journal Articles

Randomized, Phase II Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed, Refractory CLL

David L. Porter, MD, Noelle V. Frey, MDMS, J. Joseph Melenhorst, PhD, Wei-Ting Hwang, PhD, Simon F. Lacey, PhD BSc, Pamela Shaw, PhD, Anne Chew, PhD, Stephan A. Grupp, MD PhD, James Capobianchi, Joan Gilmore, Michael Kalos, PhD, Manuel Litchman, MD, Lester Lledo, RN,MSN,CNP, Alison Wakoff Loren, MDMS, Yolanda Mahnke, PhD, Katherine T. Marcucci, PhD, Holly McConville, RN, Angela Shen, MD, Patricia A. Wood, MD PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 1982.
https://doi.org/10.1182/blood.V124.21.1982.1982
Published: 2014
Journal Articles

Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL

David L. Porter, MD, Michael Kalos, PhD, Noelle V. Frey, MD, Stephan A. Grupp, MD, PhD, Alison W. Loren, MD, Christina Jemison, RN, Joan Gilmore, Holly McConville, RN, BSN, James Capobianchi, Lester Lledo, CRNP, Anne Chew, PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 4162.
https://doi.org/10.1182/blood.V122.21.4162.4162
Published: 2013
Journal Articles

Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) In Patients With Relapsed, Refractory CLL

David L. Porter, MD, Michael Kalos, PhD, Noelle V. Frey, MD, Stephan A Grupp, MD, PhD, Alison W. Loren, MD, Christina Jemision, RN, Joan Gilmore, Holly McConville, RN, BSN, James Capobianchi, Lester Lledo, CRNP, Anne Chew, PhD, Angela Shen, MD, Patricia A. Wood, MD, PhD, Manuel Litchman, MD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 873.
https://doi.org/10.1182/blood.V122.21.873.873
Published: 2013
Journal Articles

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Aaron P. Rapoport, MD, Nicole A. Aqui, MD, Edward A. Stadtmauer, MD, Ashraf Z. Badros, MD, Dan T. Vogl, MD, MSCE, YinYan Xu, Brendan M Weiss, MD, Ling Cai, PhD, Hong-Bin Fang, PhD, Elizabeth Veloso, RN, JD, Zhaohui Zheng, MA, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Sunita Philip, Kathleen Ruehle, RN, Kelly-Marie Betts, MS, Anne Chew, PhD, Holly McConville, RN, BSN, Sandra Westphal, Scott Strome, Andres Salazar, MD, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 352.
https://doi.org/10.1182/blood.V120.21.352.352
Published: 2012
Journal Articles

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nick J. Pumphrey, PhD, Dominic P. Smethurst, MD, Helen K. Tayton-Martin, PhD, Ribeiro C. Lilliam, MBe, Elizabeth Veloso, JD, BSN, Zhaohui Zheng, MA, Ashraf Z. Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Holly McConville, RN, BSN, Naseem Kerr, MPH, Sunita Philip, MPH, Kelly-Marie Betts, MS, Sandra Westphal, Michael Kalos, PhD, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 472.
https://doi.org/10.1182/blood.V120.21.472.472
Published: 2012
Journal Articles

Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1

Michael Kalos, PhD, Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Dominic P. Smethurst, MD, Irina Kulikovskaya, Minnal Gupta, Timothy L Macatee, Jeffrey M Finklestein, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nick J. Pumphrey, PhD, Helen K. Tayton-Martin, PhD, Elizabeth Veloso, JD, BSN, Zhaohui Zheng, MA, Ashraf Z. Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Holly McConville, RN, BSN, Sunita Philip, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 755.
https://doi.org/10.1182/blood.V120.21.755.755
Published: 2012